Neoangiogenesis is crucial for tumor growth and metastasis and is regulated by various angiogenic factors including vascular endothelial growth factor (VEGF). However, little is known whether highly metastatic cells express higher level of VEGF in response to various stimuli, thereby increasing neoangiogenesis compared to low-metastatic cells. Here we report that hypoxia markedly induced the expression of VEGF mRNA in the cell lines with high-metastatic potential (A11 and D6 cells) compared to the cell lines with low-metastatic potential (P29 and P34 cells) established from Lewis lung carcinoma. A11 cells exhibited higher VEGF genepromoter activity, produced a larger amount of VEGF and showed higher activity to induce neoangiogenesis than P29 cells. Although the degradation rate of VEGF mRNA under hypoxic conditions was similar in both cell lines, hypoxia-inducible factor-1a (HIF-1a) mRNA, but not HIF-1b mRNA, was found to be constitutively upregulated in A11 cells compared to P29 cells. Accordingly, the level of HIF-1a protein in response to hypoxia was higher in A11 cells than in P29 cells. Upregulation of HIF-1a mRNA was also observed in D6 cells but not in P34 cells. Thus, the high-metastatic cells produced a larger amount of VEGF under hypoxic conditions through constitutive HIF-1a mRNA upregulation compared to the low-metastatic cells, thereby leading to extensive neoangiogenesis.
Introduction
Tumor angiogenesis enables malignantly transformed cells to grow and metastasize. This process is mediated by a variety of angiogenic factors produced by tumor and host cells. The involved factors include vascular endothelial growth factor/vascular permeability factor (VEGF/VPF), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), transforming growth factor-a (TGF-a), TGF-b, hepatocyte growth factor, thymidine phosphorylase/PD-ECGF, interleukin 8 and TNF-a (Folkman, 1995; Kerbel, 2000) . Among them, involvement of VEGF in tumor angiogenesis has been intensively studied. VEGF mRNA levels are closely correlated with tumor angiogenesis (Asano et al., 1995; Zhang et al., 1995; Cheng et al., 1996; Saleh et al., 1996; Mori et al., 1999; Kondo et al., 2000; Ho¨pfl et al., 2002) . Transfection of the gene for VEGF into tumor cells such as breast carcinoma cells (Zhang et al., 1995) , fibrosarcoma cells (Mori et al., 1999) and colon carcinoma cells (Kondo et al., 2000) resulted in increases in vascularization and in vivo growth rate. Conversely, expression of VEGF antisense or neutralizing anti-VEGF antibody led to retarded growth of glioblastomas in vivo (Asano et al., 1995; Cheng et al., 1996; Saleh et al., 1996) . Importantly, it has been shown that VEGF can be used as a sensitive marker for prognosis (Kaya et al., 2000; Lee et al., 2000; Seo et al., 2000) .
Most solid tumors harbor areas of low oxygen tension (hypoxia). Tumor cells in hypoxic microenvironments, especially in perinecrotic areas, produce VEGF to stimulate neoangiogenesis (Goldberg and Schneider, 1994) . Hypoxic induction of VEGF is regulated at both transcriptional and post-transcriptional levels (Ikeda et al., 1995) . Hypoxia activates the transcriptional complex termed hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an oxygenregulated a subunit (HIF-1a) and a constitutively expressed b subunit (HIF-1b/aryl hydrocarbon receptor nuclear translocator), both subunits being members of a subfamily of basic helix-loop-helix proteins that contain a conserved PAS domain (Wenger and Gassmann, 1997; Hofer et al., 2002) . HIF-1 binds to the hypoxia response element (HRE) located upstream of the VEGF gene and transactivates its expression (Forsythe et al., 1996) . In most cases, HIF-1a cannot be detected in normoxic cells, because it is subjected to rapid ubiquitylation and proteasomal degradation mediated by O 2 -regulated proline hydroxylation and subsequent recognition by the von Hippel-Lindau (VHL) tumorsuppressor E3 ligase complex (Maxwell et al., 1999; Ivan et al., 2001 ). When exposed to hypoxia, HIF-1a is stabilized instantaneously (Jaakkola et al., 2001; Jewell et al., 2001) . The post-transcriptional regulation of VEGF mRNA involves the stabilization of the mRNA by the RNA-binding protein HuR, the binding site of which resides in the VEGF mRNA 3 0 -untranslated region (Goldberg-Cohen et al., 2002) . Besides hypoxia, VEGF gene expression is also induced by bFGF, EGF, TGF-b, TNF-a and platelet-derived growth factor (Finkenzeller et al., 1992; Goldman et al., 1993; Pertovaara et al., 1994; Ryuto et al., 1996) .
Although it is well documented that tumor angiogenesis is essential for tumor growth and is correlated with poor prognosis, it is still obscure whether highly malignant cells, especially highly metastatic tumor cells, produce a larger amount of VEGF than less malignant ones. Accordingly, we compared the expression levels of VEGF mRNA in response to hypoxia, growth factors and cytokines between high-and low-metastatic cell lines derived from Lewis lung carcinoma. We describe here that highly metastatic cell lines express a larger amount of VEGF in response to hypoxia through constitutive upregulation of HIF-1a mRNA compared to the low-metastatic ones, thereby leading to highly augmented neoangiogenesis.
Results

Metastatic potential of the cell lines
Experimental and spontaneous metastatic abilities of the cell lines used in this study are summarized in Table 1 . A11 cells showed high-metastatic potential, while P29 and P34 cells were low metastatic. D6 cells exhibited intermediate metastatic potential.
VEGF expression in response to hypoxia and various factors
We first examined whether there is a difference in the expression of VEGF mRNA in response to hypoxia between P29 and A11 cells. Upon culturing them under hypoxic conditions for varying time points, the expression levels of VEGF mRNA in A11 cells were significantly induced compared to P29 cells (Figure 1a) . The induction of VEGF mRNA in A11 cells was detectable as early as 3 h after hypoxic exposure, while it was not observed until 6 h in P29 cells (Figure 1a ). Hypoxic induction of VEGF mRNA in D6 cells was slightly higher than that in A11 cells, but it was low in P34 cells (Figure 1b) . We also examined the expression of VEGF mRNA in P29 and A11 cells treated with For assay of experimental metastasis, cells (1 Â 10 5 cells/mouse) were injected into the tail vein of 6-week old female C57BL/6 (7 mice/ group). To define spontaneous metastasis, cells (2.5 Â 10 5 cells/mouse) were injected into the abdominal flank of female C57BL/6 mice (7 mice/group) VEGF mRNA expression in P29, P34, D6 and A11 cells exposed to normoxia (N) or hypoxia (H) for 6 h. (c) VEGF mRNA expression in P29 and A11 cells treated with TGF-a (10 ng/ml), TGF-b (10 ng/ml), EGF (100 ng/ ml), TNF-a (10 ng/ml) or bFGF (10 ng/ml) for 6 h. Total RNA isolated from the cells was subjected to Northern blot analysis. Blots were hybridized with a 32 P-labeled VEGF cDNA. Ethidium bromide staining of the gels is shown below each blot VEGF and HIF-1a overexpression in highly metastatic cells N Koshikawa et al TGF-a, TGF-b, EGF, TNF-a and bFGF, all factors being reported to stimulate VEGF expression (Finkenzeller et al., 1992; Ryuto et al., 1996; Goldman et al., 1993; Pertovaara et al., 1994) . Of these, TGF-b and bFGF induced the VEGF mRNA expression in both cell lines (Figure 1c ). However, the induction level was low and nearly equal in both cell lines. We also measured the amount of VEGF secreted by these cell lines into culture supernatants. As shown in Figure 2 , basal levels of VEGF were already higher in D6 and A11 cells, compared to those in P29 and P34 cells and the difference increased further upon culturing the cells for 18 h under hypoxic conditions. Thus, there is a marked difference in hypoxia-induced VEGF mRNA expression between the high-and the low-metastatic cell lines.
Comparison of in vivo angiogenesis between low-and high-metastatic cells
To investigate whether the difference in the expression of VEGF in response to hypoxia reflects the degree of angiogenesis in vivo, we compared the abilities of P29 and A11 cells to induce new vasculature in the mouse dorsal air sac assay. Compared to P29 cells, A11 cells markedly induced new blood vessels with the characteristic zigzagging pattern of tumor cellinduced new vasculature ( Figure 3a ). Blood vessel density was about doubled in A11 tumors compared to P29 tumors when assessed by CD31 immunostaining of cryosections prepared from subcutaneous tumors of nearly equal size (Figure 3b and c). Of note, capillaries in P29 tumors were relatively thick, while those in A11 tumors were thinner. Although A11 cells proliferated slower than P29 cells in vitro, A11 cells formed subcutaneous tumors faster than P29 cells, perhaps due to their higher ability to induce neoangiogenesis (data not shown).
VEGF mRNA stability under hypoxic conditions in low-and high-metastatic cells
To elucidate the molecular mechanisms underlying the difference in VEGF mRNA expression between P29 and A11 cells, we first examined the stability of VEGF mRNA in hypoxically cultured cells. For this purpose, P29 and A11 cells that had been exposed to hypoxia for 7 h were further incubated under hypoxic conditions for up to 2 h in the presence of actinomycin D. As shown in Figure 4a , the VEGF mRNA degraded rapidly in both P29 and A11 cells. By normalizing the intensities of the bands to those of 28S rRNA, it appeared that the degradation rate of the VEGF mRNA was not significantly different between both cell lines ( Figure 4b ).
VEGF gene-promoter activity in low-and high-metastatic cells P29, P34, D6 and A11 cells were transiently transfected with the luciferase reporter plasmid harboring mouse VEGF gene-promoter region encompassing the HRE site and cultured for a total of 48 h. During the last 18 h, the cells were subjected to hypoxia, and cell lysates were assayed for luciferase activity. The results showed that the luciferase activity in D6 and A11 cells was already higher than that in P29 and P34 cells under normoxic conditions ( Figure 5 ). Exposure of the cells to hypoxia resulted in a 2-3-fold increase in luciferase activity in all cell lines, but the activity was higher in D6 and A11 cells than that in P29 and P34 cells ( Figure 5 ). Expression of the HIF-1 subunits in low-and high-metastatic cells
Next, we examined the expression levels of HIF-1a and HIF-1b mRNA in P29 and A11 cells. The steady-state level of HIF-1a mRNA was several-fold higher in A11 cells than in P29 cells (Figure 6a ). By contrast, the level of HIF-1b mRNA in P29 and A11 cells, as assessed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR), was almost equal (Figure 6b) . A higher expression of HIF-1a mRNA was also observed in D6 cells, but not in P34 cells (Figure 6c ). Unlike the expression of VEGF mRNA, the amounts of HIF-1a and HIF-1b mRNAs were constant during hypoxia. At the protein level, HIF-1a was not detectable in the nuclear extracts of both normoxic P29 and A11 cells (Figure 6d ). However, after exposure to hypoxia for 4 h, HIF-1a was significantly induced in A11 cells but still undetectable in P29 cells. After further exposure to hypoxia for 12 h, HIF-1a was clearly detectable in P29 cells, but the amount was still lower than that in A11 cells (data not shown).
Discussion
We demonstrated here that hypoxia markedly induced VEGF production and VEGF mRNA expression in high-metastatic A11 cells compared to low-metastatic P29 cells. We also found that A11 cells induced neoangiogenesis more extensively than P29 cells, as confirmed independently by either mouse dorsal air sac assay or immunostaining of microvessels. It should be noted that A11 tumors contain many thin vessels. This would increase the chance of intravasation, and consequently metastasis, of these cells. Both A11 and P29 cells responded weakly to other inducers of VEGF such as TGF-b and bFGF. However, no difference was observed in their responsiveness to these factors. Therefore, hypoxia, but not TGF-b and bFGF, may primarily contribute to the observed difference in neoangiogenesis. Hypoxia also induced VEGF mRNA expression in D6 cells at a slightly higher level of that in A11 cells, regardless of their intermediate and high metastatic potential. These results suggest that a higher VEGF production is required, but not sufficient, for the full expression of metastatic potential. In addition to the present results, we have recently found that high-metastatic mouse melanoma B16BL6 cells and highly invasive human breast carcinoma MDA-MB-231 cells produce a larger amount of VEGF and VEGF mRNA than low-metastatic B16F1 and lessmalignant MCF-7 cells, respectively, under hypoxic conditions (unpublished observations). Therefore, it is likely that most highly malignant tumor cell lines, especially the metastatic ones, produce a larger amount of VEGF than less-malignant tumor cell lines.
It is well known that VEGF mRNA is stabilized under hypoxic conditions (Goldberg-Cohen et al., 2002) . As a first step to investigate the molecular mechanisms underlying the difference in VEGF mRNA expression Figure 4 VEGF mRNA stability in P29 and A11 cells under hypoxic conditions. (a) P29 and A11 cells were exposed to normoxia (N; 20% O 2 , 5% CO 2 ) or hypoxia (H; 2% O 2 , 5% CO 2 ) for 7 h. After addition of 5 mg/ml of actinomycin D (Act. D), they were further incubated under hypoxic conditions for up to 2 h. Total RNA was extracted and subjected to Northern blot analysis. The blots were hybridized with either a 32 P-labeled VEGF cDNA probe or an 28S ribosomal DNA probe. (b) After semiquantifying the intensities of bands, the levels of the VEGF mRNA were normalized to those of 28S ribosomal RNA. Bars, s.d. Figure 5 VEGF promoter activity in P29, P34, D6 and A11 cells measured by luciferase reporter assay. Luciferase activities were obtained from P29, P34, D6 and A11 cells that were transiently transfected with pGLV (HRE) Luc. The cells were exposed to normoxia (N) or hypoxia (H) for 18 h. All luciferase activities were normalized for transfection efficiency, and background luciferase activities obtained from each cell transfected with a promoterless luciferase gene pGL2-basic were subtracted from this value. Bars, s.d.
VEGF and HIF-1a overexpression in highly metastatic cells N Koshikawa et al observed above, the degradation rate of VEGF mRNA under hypoxic conditions was compared between P29 and A11 cells. The results showed that it was almost equal in both cell lines, suggesting that there is no qualitative difference in the machinery that participates in the stabilization of VEGF mRNA under hypoxic conditions. Next, we measured the VEGF gene-promoter activity and found that it was much higher in D6 and A11 cells than in P29 and P34 cells under hypoxic conditions. Subsequently, Northern blot analysis revealed a constitutive upregulation of HIF-1a mRNA in A11 and D6 cells. Consistent with the results, the induction of HIF-1a after exposure to hypoxia was more rapid and higher in A11 cells than in P29 cells. Thus, it seems likely that the overexpression of VEGF, VEGF mRNA and HIF-1a in hypoxic D6 and A11 cells is mainly attributed to the constitutive upregulation of HIF-1a mRNA.
In Western blot analysis, we could not detect HIF-1a in P29 and A11 cells under normoxic conditions. Nevertheless, the VEGF gene-promoter activity in A11 cells was already higher than that in P29 cells. The reason is presently unclear. Of note, however, that the deletion of the HRE site from the VEGF gene-promoter almost abolished its activity in A11 cells in both normoxia and hypoxia (Koshikawa et al., 2000) . This suggests that the VEGF gene-promoter activity observed in normoxic cells is also dependent on HIF-1a. Taking into consideration that HIF-1a mRNA is upregulated in A11 cells, it is possible that HIF-1a is expressed in normoxic A11 cells at a higher level, but at a level below the limits of detection, than in normoxic P29 cells. It may also be possible that the degradation rate of HIF-1a in A11 cells is slower than that in P29 cells. HIF-1a has been shown to be rapidly targeted to ubiquitin-proteasome degradation pathway after recognizing by VHL E3 ligase complex under normoxic conditions (Ivan et al., 2001; Jaakkola et al., 2001; Jewell et al., 2001) . In addition, p53 is reported to promote Mdm2-mediated ubiquitylation and proteasomal degradation of HIF-1a (Ravi et al., 2000) . We then compared the expression levels of VHL, Mdm2 and p53, the gene of which is mutated in Lewis lung carcinoma cells, between A11 and P29 cells. However, no differences were observed (data not shown), suggesting that HIF-1a is probably degraded in both cell lines at the same rate under normoxic conditions. Recent studies provide evidence that HIF-1a is overexpressed in breast metastases than in primary breast cancers (Zhong et al., 1999) and that overexpression of P29 and A11 cells were exposed to normoxia (N) or hypoxia (H) for 6 h. Using total RNA isolated from the cells, HIF-1b and GAPDH mRNA expression were examined by RT-PCR analysis. (c) P29, P34, D6 and A11 cells were exposed to normoxia (N) or hypoxia (H) for 6 h. Total RNA was extracted and subjected to Northern blot analysis. The blots were hybridized with a 32 P-labeled HIF-1a cDNA probe. Ethidium bromide staining of the gels is shown below. (d) Nuclear extracts prepared from P29 and A11 cells exposed to normoxia (N) or hypoxia (H) for 4 h were dissolved by SDS-PAGE. HIF-1a and c-Jun, which served as a control, were detected by immunoblotting VEGF and HIF-1a overexpression in highly metastatic cells N Koshikawa et al HIF-1a is a marker for poor prognosis in invasive cervical cancer and lymph-node-positive breast cancer (Birner et al., 2000; Schindl et al., 2002) . The overexpression of HIF-1a in these cancers may be explained by aberrant HIF-1a stability caused by many factors including tumor hypoxia and inactivation of VHL and p53 genes. Besides, our results indicate for the first time a possible involvement of aberrant regulation of HIF-1a gene expression in these factors. Studies on the mechanism of constitutive upregulation of HIF-1a mRNA and the expression of HIF-1a mRNA in human cancers are interesting issues to be pursued.
The present and the previous studies (Zhong et al., 1999; Birner et al., 2000; Schindl et al., 2002) suggest the significance of HIF-1a as a biomarker of metastatic potential. Therefore, HIF-1a could be an important target for preventing metastasis. As such, suppression of HIF-1a, employing the techniques such as the transmission decoy technique (Rose et al., 2002) , would be intriguing to suppress tumor metastasis.
Materials and methods
Reagents
Human recombinant TNF-a, EGF and TGF-a were purchased from Invitrogen (Groningen, The Netherlands). Human TGF-b and bFGF were obtained from Takara Biomedicals (Osaka, Japan) and Pepro Teck EC Ltd (London, UK), respectively.
Cell lines and cell culture
The characteristics of P29, P34, D6 and A11 cells, all of which are derived from Lewis lung carcinoma, are described elsewhere (Takenaga et al., 1994 (Takenaga et al., , 1997 Takasu et al., 1999; Koshikawa et al., 2000) . They were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with heatinactivated (561C, 30 min) fetal bovine serum (FBS), 100 U/ml of penicillin and 100 mg/ml of streptomycin. They were also cultured in hypoxic environment in a BBL GasPak Pouch anaerobic system (Becton Dickinson, Cockeysville, MA, USA), which reduces oxygen tension to less than 2% within 2 h, or in NAPCO s automatic O 2 /CO 2 incubator (Precision Scientific, Chicago, IL, USA).
Evaluation of metastatic potential
To test their metastatic potential, cells (1 Â 10 5 cells/mouse) were injected into the tail vein of 6-week-old female C57BL/6 mice (Nippon SLC, Hamamatsu, Japan). The mice were killed 17 days after injection and lungs were removed. To define spontaneous metastasis, cells (2.5 Â 10 5 cells/mouse) were injected into the abdominal flank of age-matched female C57BL/6 mice and lungs were removed 30 days later. The lungs were fixed in Bouin's solution and the parietal nodules were counted under a dissecting microscope (Takenaga et al., 1994; Takasu et al., 1999) .
In vivo tumor angiogenesis
Tumor-associated angiogenesis was examined by the mouse dorsal air sac assay (Folkman et al., 1971) . Cells were washed twice with Dulbecco's phosphate-buffered saline (DPBS) and suspended in DPBS at 4.7 Â 10 7 cells/ml. A Millipore chamber (diameter, 10 mm; thickness, 2 mm; filter pore size, 0.22 mm) was filled with 150 ml (7 Â 10 6 cells) of cell suspension. DPBS alone served as a control. The chamber was implanted s.c. into an air sac formed previously in the dorsum of 8-week-old female C57BL/6 mice. On day 3, the implanted chambers were removed from the s.c. fascia of the mice. Tumor cell-induced new vasculature in the s.c. side of the skin area that had been contact with the chamber was assessed under a dissecting microscope.
Immunohistochemistry
Subcutaneous tumors were surgically removed and immediately frozen in OCT compound. Cryostat sections were fixed with cold acetone, treated with 3% hydrogen peroxide in methanol for 10 min, and incubated with DPBS containing 10% normal sheep serum. They were then incubated with rat anti-mouse monoclonal CD31 antibody (PharMingen, San Diego, CA, USA). Sections were washed with DPBS and incubated with biotinylated sheep anti-rat IgG. After washing with DPBS, immunocomplexes were detected using the ABC method with diaminobenzidine as a substrate. Sections were finally counterstained with hematoxylin. CD31-stainable capillaries were counted at Â 100 magnification in randomly selected nine fields.
RNA extraction and northern blot analysis
Total RNA was extracted with guanidinium thiocyanate from cells cultured under normoxic or hypoxic environment. Total RNA (20 mg) was electrophoresed on 1% agarose gel containing formaldehyde and transferred onto nylon filters. Blots were hybridized with a 32 P-labeled mouse VEGF cDNA or a mouse HIF-1a cDNA probe (a generous gift of Dr CA Bradfield, McArdle Laboratory for Cancer Research), which was prepared by the random primer method. Filters were finally washed at 501C in 30 mm NaCl, 3 mm sodium citrate and 0.1% SDS.
Determination of VEGF protein levels in culture supernatants
Cells were seeded at 2 Â 10 5 cells/well of a 12-well plate (Falcon 3043) and allowed to adhere for 4 h in DMEM containing 10% FBS. After changing the medium, the cells were cultured for 18 h under normoxic or hypoxic conditions. Cell supernatants were collected, filtered and stored at À201C, and concomitantly, cells were harvested by trypsinization, and cell number was determined. The amount of VEGF in the supernatant was determined with an enzyme-linked immunosorbent assay kit (Quantikine, R&D Systems, Mineapolis, MN) according to the manufacturer's instructions. VEGF was expressed as picograms of VEGF protein/10 5 cells/18 h.
VEGF mRNA stability under hypoxic conditions
A11 and P29 cells were exposed to hypoxia (2% O 2 , 5% CO 2 ) for 7 h in an automatic O 2 /CO 2 incubator. After addition of 5 mg/ml of actinomycin D, they were further incubated under hypoxic conditions for up to 2 h. Total RNA was extracted and subjected to Northern blot as described above. Blots were hybridized with either a 32 P-labeled VEGF cDNA probe or an 28S ribosomal DNA probe. After semiquantifying the intensities of bands by Bio Image s Intelligent Quantifiert (version 2.2.1, B. I. Systems Corp., Ann Arbor, MI, USA), the levels of the VEGF mRNA were normalized to those of 28S ribosomal RNA.
RT-PCR analysis
Target mRNA was first transcribed into cDNA using oligo(dT) 12-18 primer and Moloney murine leukemia virus reverse transcriptase. The resulting cDNAs were used for the amplification of the HIF-1b cDNA using the sense and antisense primers and rTaq DNA polymerase (TOYOBO Biochemicals, Tokyo, Japan). The sense and the antisense primers for RT-PCR were 5 0 -GACAGAGATCCAAGGTT-TCCAG-3 0 and 5 0 -TGGGAAAGGGTACATATCAGGG-3 0 , respectively. The condition for the PCR was 951C for 0.5 min, 551C for 0.5 min and 721C for 1.5 min, and the cycle was repeated 18, 23, 28 and 33 times. Aliquots of the PCR products were fractionated by electrophoresis in 2% agarose gels and visualized on a transilluminator after staining with ethidium bromide.
Luciferase reporter plasmid constructs and luciferase assays
Mouse VEGF gene-promoter sequence containing the HRE site was inserted upstream of the luciferase gene in a pGL2-basic vector (Promega Corp., Madison, WI, USA), yielding plasmid pGLV[HRE]Luc (Koshikawa et al., 2000) . Transient transfection was carried out using Lipofectin (Invitrogen). As a control for transfection efficiency, pRL-TK vector (Promega) was cotransfected with test plasmids. pGL2-control vector (Promega) was used as a positive control. Luciferase activity in cell extracts was assayed 48 h post-transfection according to Dual-Luciferase TM reporter assay system protocols (Promega) using a luminometer (model TD-20/20, Turner Designs, Sunnyvale, CA, USA).
Preparation of nuclear extract
Nuclear extracts were prepared as described previously (Wang and Semenza, 1995) , using buffer A and buffer C in which a proteasome inhibitor, Z-Leu-Leu-Nva-H (aldehyde) (Peptide Institute Inc., Osaka, Japan), was also added at a concentration of 10 mg/ml. Cells were lysed by 20 strokes in a glass Dounce homogenizer with type B pestle. Nuclei were pelleted at 10 000 g for 10 min and extracted by stirring at 41C for 30 min in Buffer C. Nuclear proteins were collected after centrifugation at 15 000 g for 30 min, and dialyzed against buffer Z-100 at 41C (Wang and Semenza, 1995) . The dialysate was clarified by centrifugation at 100 000 g for 60 min at 41C. The nuclear extracts were stored at -801C until use.
SDS-PAGE and immunoblot analysis
Proteins in nuclear extracts (30 mg protein) were resolved by SDS-polyacrylamide gel (SDS-PAGE) electrophoresis under reducing conditions. Protein concentration was determined by the method of Bradford (1976) using bovine serum albumin as a standard. The resolved proteins were electrophoretically transferred to nitrocellulose membrane. After blocking with 5% dry milk in TBS-T (150 mm NaCl, 50 mm Tris-HCl, pH 7.4, 0.05% Tween 20), the membrane was incubated with chicken anti-HIF-1a antibodies (Camenisch et al., 1999) or rabbit anti-c-Jun antibodies (Oncogene Science Inc., Manhasset, NY, USA). The membrane was washed extensively with TBS-T, and then incubated with horse raddish peroxidaseconjugated rabbit anti-chicken IgY (Promega) or goat antirabbit IgG, respectively. HIF-1a and c-Jun were detected using ECL Western blotting detection reagents (Amersham Biosciences Corp., Piscataway, NJ, USA).
